| Ironwood Pharmaceuti (IRWD) | |||
|---|---|---|---|
| 11.7 -0.17 (-1.43%) | 08-08 16:00 | ||
| Open: | 11.95 | Pre. Close: | 11.87 |
| High: | 11.965 | Low: | 11.515 |
| Volume: | 2,652,914 | Market Cap: | 1,800M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 11.977 - 12.038 | 12.038 - 12.085 |
| Low: | 11.38 - 11.443 | 11.443 - 11.492 |
| Close: | 11.599 - 11.706 | 11.706 - 11.788 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 14.59 One year: 17.04 |
| Support: | Support1: 11.43 Support2: 10.78 |
| Resistance: | Resistance1: 12.49 Resistance2: 14.59 |
| Pivot: | 11.69  |
| Moving Averages: | MA(5): 11.41 MA(20): 11.72 MA(100): 11.84 MA(250): 11.96 |
| MACD: | MACD(12,26): -0.05 Signal(12,26,9): -0.02 |
| %K %D: | %K(14,3): 52.83 %D(3): 39.51 |
| RSI: | RSI(14): 50.57 |
| 52-Week: | High: 14.27 Low: 10.13 Change(%): -12.5 |
| Average Vol(K): | 3-Month: 3932 10-Days: 3221 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ IRWD ] has closed below upper band by 49.2%. Bollinger Bands are 51.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: NASDAQ Global Select | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers—Specialty & Generic | |
| Shares Out. (M) | 153.84 |
| Shares Float (M) | 134.43 |
| % Held by Insiders | 1.80 |
| % Held by Institutions | 111.75 |
| Shares Short (K) | 17510 |
| Shares Short Prior Month (K) | 14080 |
| Stock Financials | |
|---|---|
| EPS | 3.290 |
| Book Value (p.s.) | 3.340 |
| Profit Margin | 124.83 |
| Operating Margin | 57.91 |
| Return on Assets (ttm) | 18.2 |
| Return on Equity (ttm) | 167.9 |
| Qtrly Rev. Growth | 9.8 |
| Gross Profit (p.s.) | 2.232 |
| Sales Per Share | 2.746 |
| EBITDA (p.s.) | 1.600 |
| Qtrly Earnings Growth | -15.10 |
| Operating Cash Flow (M) | 252.32 |
| Levered Free Cash Flow (M) | 147.22 |
| Stock Valuation | |
|---|---|
| PE Ratio | 3.56 |
| PEG Ratio | 0.13 |
| Price to Book value | 3.50 |
| Price to Sales | 4.26 |
| Price to Cash Flow | 7.13 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
